FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (GLENMARK THERAPEUTICS INC., USA)

View source ↗

Summary

The FDA approved Glenmark Therapeutics' olopatadine hydrochloride as an original ANDA, permitting the marketing of a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• OLOPATADINE HYDROCHLORIDE (olopatadine hydrochloride)

Snippet

ORIG AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE)